Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes

A N Naegeli, R P Hayes, A N Naegeli, R P Hayes

Abstract

Aim: The aim of this study was to investigate how patients' expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction.

Methods: The Expectations about Insulin Therapy (EAITQ) and the Experience with Insulin Therapy Questionnaires (EWITQ) were administered at baseline and end-point, respectively to insulin-naïve patients with type 2 diabetes in a randomised trial comparing treatment algorithms for inhaled insulin. Pearson correlation coefficients were calculated between EAITQ and EWITQ scores, patient characteristics and patient-reported outcomes measures. Wilcoxon Signed Rank test compared EAITQ and EWITQ item score distributions. Differences between EAITQ and EWITQ scores were calculated to categorize patients according to the extent to which their expectations were met by experiences (i.e. unmet, met, exceeded).

Results: EAITQ and EWITQ data were available for 240 patients (61% male, mean age 58 years, mean diabetes duration 10 years, mean baseline HbA(1c) 8.4%). Increasingly positive expectations were significantly associated with greater self-efficacy; greater levels of positive experiences were significantly associated with greater positive expectations, shorter diabetes duration, less symptom distress, greater well-being, self-efficacy and diabetes treatment satisfaction. Overall, patients' experiences with inhaled insulin therapy were significantly more positive than their expectations: 58% patients' experiences exceeded expectations, 29% patients' experiences met expectations and 13% patients' experiences did not meet expectations. Post hoc tests indicated that treatment satisfaction scores differed among these groups (all p < 0.01).

Conclusion: Expectations may not independently impact treatment satisfaction, but the relationship with experiences significantly contributes to it. The EAITQ and EWITQ may be useful tools for clinicians to better understand patients' expectations about and experiences with insulin therapy.

Trial registration: ClinicalTrials.gov NCT00391209.

Figures

Figure 1
Figure 1
Differences in Diabetes Treatment Satisfaction Scores based on the extent to which patients’ expectations about insulin therapy are exceeded by experiences

References

    1. Kravitz RL, Callahan EJ, Paterniti D, Antonius D, Dunham M, Lewis CE. Prevalence and sources of patients; Unmet expectations for care. Ann Intern Med. 1996;125:730–7.
    1. Kravitz RL. Patients’ expectations for medical care: an expanded formulation based on review of the literature. Med Care Res Rev. 1996;53:3–27.
    1. Zemencuk JK, Feightner JW, Hayward RA, et al. Patients’ desires and expectations for medical care in primary care clinics. J Gen Intern Med. 1998;13:273–6.
    1. Miller CK, Gutschall MD, Lawrence F. The development of self-efficacy and outcome expectation measures regarding glycaemic load and the nutritional management of type 2 diabetes. Public Health Nutr. 2007;10:628–34.
    1. Brod M, Cobden D, Lammert M, Bushnell D, Raskin P. Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues. Health Qual Life Outcomes. 2007;5:8.
    1. Szeinbach SL, Barnes JH, Summers KH, Lenox SM. Development of an instrument to assess expectations of and preference for an insulin injection pen compared with the vial and syringe. Clin Ther. 2004;26:590–7.
    1. Kumar RN, Kirking DM, Hass SL, et al. The association of consumer expectations, experiences and satisfaction with newly prescribed medications. Qual Life Res. 2007;16:1127–36.
    1. Lee DS, Tu JV, Chong A, et al. Patient satisfaction and its relationship with quality and outcomes of care after acute myocardial infarction. Health Serv Outcomes Res. 2008;118:1938–45.
    1. Lawton J, Parry O, Peel E, Douglas M. Diabetes service provision: a qualitative study of newly diagnosed type 2 diabetes patients’ experiences and views. Diabet Med. 2005;22:1246–51.
    1. Lawton J, Peel E, Parry O, et al. Patients’ perceptions and experiences of taking oral glucose-lowering agents. Diabet Med. 2008;25:491–5.
    1. Patrick DL, Martin ML, Bushnell DM, Pesa J. Measuring satisfaction with migraine treatment: expectations, Importance, Outcomes, and Global Ratings. Clin Ther. 2003;25:2920–35.
    1. Finch EA, Linde JA, Jeffery RW, Rothman AJ, King CM. The effects of outcome expectations and satisfaction on weight loss and maintenance: correlational and experimental analyses – a randomized trial. Health Psychol. 2005;24:608–16.
    1. Kinmonth AL, Murphy E, Marteau T. Diabetes and its care-what do patients expect? J Rl Coll Gen Pract. 1989;39:324–7.
    1. Petrak F, Stridde E, Leverkus F, Crispin AA, Pfutzner A. Development and validation of a new measure to evaluate psychological resistance to insulin treatment. Diabetes Care. 2007;30:2199–204.
    1. Carver C. Insulin treatment and the problem of weight gain in type 2 diabetes. Diabetes Educ. 2006;32:910–7.
    1. Mollema ED, Snoek FJ, Ader HJ, Heine RJ, van der Ploeg HM. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing; Psychological comorbidity and general well-being. J Psychosom Res. 2001;51:665–72.
    1. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes. Diabetes Care. 2005;28:2543–5.
    1. Stotland NL. Overcoming psychological barriers in insulin therapy. Insulin. 2006;1:38–45.
    1. Funnell MM. Overcoming barriers to the initiation of insulin therapy. Clin Diabetes. 2007;25:36–8.
    1. Hayes RP, Nakano M, Muchmore D, Schmitke J. Effect of standard (self-directed) training versus intensive training for Lilly/Alkermes human insulin inhalation powder delivery system on patient-reported outcomes and patient evaluation of the system. Diabetes Technol Ther. 2007;9:89–98.
    1. Peyrot M, Rubin RR, Lauritzen T, et al. Resistance to insulin therapy among patients and providers. Diabetes Care. 2005;28:2673–9.
    1. Fisher EB, Thorpe CT, DeVellis BM, DeVellis RF. Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal. Diabetes Educ. 2007;33:1080–103.
    1. Hayes RP, Fitzgerald JT. Perceptions, attitudes, and knowledge influence insulin delivery system satisfaction more than system used in people with type 2 diabetes. 2008. 2008 International Society for Quality of Life Research meeting abstracts. The QLR Journal, A-17, Abstract #1289.
    1. Mathieu C, Cuddihy R, Arakaki R, et al. A comparison between simplified and intensive dose-titration algorithms using AIR® Inhaled Insulin for insulin-naïve patients with type 2 diabetes in a randomized noninferiority trial. Diabetes Technol Ther. 2009;11:S53–61.
    1. Bradley C. The diabetes treatment satisfaction questionnaire. In: Bradley C, editor. Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Chur, Switzerland: Harwood Academic Publishers; 1994. pp. 111–32.
    1. Grootenhuis PA, Snoek FJ, Heine RJ, et al. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabet Med. 1994;11:253–61.
    1. Bradley C. The 12-Item Well-Being Questionnaire: origins, current stage of development, and availability. Diabetes Care. 2000;23:875.
    1. Hayes RP, Bowman L, Monahan PO, et al. Understanding diabetes medications from the perspective of patients with type 2 diabetes. Diabetes Educ. 2006;32:404–14.
    1. Chlebowy DO, Garvin BJ. Social support, self-efficacy, and outcomes expectations: impact on self-care behaviors and glycemic control in Caucasian and African American adults with type 2 diabetes. Diabetes Educ. 2006;32:777–86.
    1. Duane J, Conway W. Weight change in intensive insulin therapy for type 2 diabetes mellitus as a function of glycosylated hemoglobin (A1C) level achieved: the Deep South Diabetes Program. Insulin. 2008;3:219–31.
    1. Hermansen K, Mortensen LS, Hermansen ML. Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease. Vasc Health Risk Manage. 2008;4:561–74.
    1. Fajardo Montanana C, Herrero CH, Fernandez MR. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients-The PREDICTIVE BMI clinical trial. Diabet Med. 2008;25:916–23.
    1. Rosenstock J, Zinman B, Murphy LJ, et al. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Ann Intern Med. 2005;143:549–58.
    1. Hayes RP, Marshall TS. The importance and correlates of insulin delivery system attributes in patients with type 2 diabetes. Diabet Med. 2006;23(Suppl. 4):195.
    1. Stockl K, Ory C, Vanderplas A, et al. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin. 2007;23:133–46.
    1. Wilson M, Moore MP, Lunt H. Treatment satisfaction after commencement of insulin in Type 2 diabetes. Diabetes Res Clin Pract. 2004;66:263–7.
    1. Witthaus E, Stewart J, Bradley C. Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes. Diabet Med. 2001;18:619–25.
    1. Bradley C, Plewe G, Kliebe-Frisch C, et al. Treatment satisfaction with a basal insulin added to oral agents versus twice-daily premixed insulin alone in patients with type 2 diabetes. Diabetes. 2005;54(Suppl. 1):A304. Abstract 1246-P.
    1. Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev. 2002;18:S64–9.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe